Crown Wealth Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Crown Wealth Group's LLY Position: Q3 2026 in Review
Crown Wealth Group reduced its Eli Lilly (LLY) stake by 7.9% in Q3 2026, selling an estimated $297K and leaving 2,939 shares worth $3.4M. The position accounts for 0.84% of the portfolio, ranked #21.
Crown Wealth Group first reported a position in LLY in Q1 2022 and has held it in 19 quarters since. The position peaked at $3.83M in Q2 2026. 1,995 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Crown Wealth Group held 2,939 shares of Eli Lilly worth $3.4M as of Q3 2026.
- Crown Wealth Group sold 252 Eli Lilly shares in Q3 2026, an estimated $297K.
- Eli Lilly made up 0.84% of Crown Wealth Group's portfolio in Q3 2026, its #21 holding.
- Crown Wealth Group first reported a position in Eli Lilly in Q1 2022 and has held it in 19 quarters since.
- Crown Wealth Group's Eli Lilly position peaked at $3.83M in Q2 2026.
- 1,995 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Crown Wealth Group's 13F filing for Q3 2026, filed 19 Oct 2026.